Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immune system can be modulated to induce tolerance to *Dermatophagoides pteronyssinus* and *Dermatophagoides farinae* allergens, shifting the immune response from an allergic state toward a regulatory state. This involves the induction of allergen-specific Tregs and B cells, production of immunosuppressive cytokines (IL-10, TGF-β), a shift in antibody profile (↑IgG4, ↓IgE), and a shift from Th2 to Th1/regulatory responses. Immunotherapy uses standardized extracts to harness these mechanisms, leading to reduced allergy symptoms upon re-exposure.
Induction of allergen-specific regulatory T cells (Tregs) and B cells; production of IL-10 and TGF-β; shift in antibody profile from IgE to IgG4 and IgA; shift from Th2 to Th1/regulatory immune responses.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System (Tolerance Induction via Exposure to Dermatophagoides pteronyssinus and Dermatophagoides farinae Allergens).